Swine Healthcare Market Report 2026

The swine healthcare market size has grown strongly in recent years. It will grow from $3.04 billion in 2025 to $3.27 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising livestock disease outbreaks, increasing pork consumption demand, expansion of commercial pig farming, government animal health initiatives, growth in veterinary service availability.

The swine healthcare market size is expected to see strong growth in the next few years. It will grow to $4.43 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to growing focus on zoonotic disease prevention, rising investment in precision livestock farming, increasing adoption of advanced vaccines, expansion of data-driven herd management, demand for sustainable animal production practices. Major trends in the forecast period include expansion of preventive vaccination programs, growth in herd health management services, rising demand for disease diagnostic testing, increased focus on biosecurity and parasite control, adoption of nutritional advisory and welfare monitoring services.

The rising pork consumption is expected to drive the growth of the swine healthcare market going forward. Pork consumption refers to the quantity of pork meat consumed by individuals or populations, commonly measured on a per capita basis over a specific period. Pork consumption is increasing due to higher disposable incomes that allow consumers to spend more on protein-rich diets. Factors contributing to swine diseases include inadequate biosecurity practices. Swine healthcare enhances pork consumption by improving animal health, productivity, and meat quality, ensuring a consistent supply of safe and high-quality pork products to meet rising consumer demand. For instance, in January 2025, according to Canada Pork International, a Canada-based promotional organization, Canada’s per capita pork consumption increased by 2.1 kg, or 14.40%, reaching 16.72 kg in 2023. Therefore, the rising pork consumption is driving the growth of the swine healthcare market.

Leading companies in the swine healthcare market are focusing on developing innovative solutions, such as dual-antigen PCV2 vaccine technology, to deliver broader and longer-lasting protection against evolving porcine circovirus strains. Dual-antigen PCV2 vaccines are formulations that incorporate antigens from multiple PCV2 genotypes to strengthen immune coverage and improve herd health outcomes. For example, in September 2025, Boehringer Ingelheim, a Germany-based provider of animal health vaccines and therapeutics, launched INGELVAC CIRCOFLEX AD, a next-generation swine vaccine designed to protect pigs against predominant PCV2 strains. The vaccine delivers a fast onset of immunity within about two weeks and provides protection for at least six months, helping reduce disease impact and improve overall herd performance. It includes a trusted adjuvant to support a robust immune response with a single intramuscular administration, offering producers a convenient and effective tool for porcine circovirus control.

In July 2024, Merck Animal Health, a US-based animal healthcare company, acquired Elanco Animal Health’s aquaculture business for an undisclosed amount. With this acquisition, Merck Animal Health strengthened its fish health and aquaculture solutions portfolio by expanding disease prevention, treatment, and sustainability offerings across global markets. Elanco Animal Health Incorporated is a US-based company specializing in aquatic animal health products such as vaccines and nutritional solutions.

Major companies operating in the swine healthcare market are Boehringer Ingelheim International GmbH, Evonik Operations GmbH, Nutreco N.V., Novonesis A/S, Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Alltech Inc., Adisseo S.A., Ceva Santé Animale S.A., Kemin Industries Inc., Neogen Corporation, Genus plc, HIPRA S.A., Dechra Pharmaceuticals plc, Vetoquinol S.A., Indian Immunologicals Limited, Bimeda Inc., Pulike Biological Engineering Inc., Merck Animal Health (MSD), Hester Biosciences Limited, Provimi B.V., Huvepharma NV, IDvet Innovative Diagnostics, Indical Bioscience GmbH, Zoetis Inc.

Tariffs are impacting the swine healthcare market by increasing the cost of imported veterinary pharmaceuticals, diagnostic kits, feed additives, and medical equipment, which raises operational expenses for farmers and veterinary service providers. Regions dependent on cross-border livestock medicine imports, particularly parts of Asia-Pacific and Latin America, experience stronger pricing pressures. Segments such as therapeutics, diagnostics, and nutritional health products are the most affected. However, tariffs are also encouraging domestic manufacturing of animal health products, local veterinary innovation, and greater investment in regional supply chains, which can strengthen long-term self-sufficiency and market resilience.

Swine healthcare refers to the management, prevention, and treatment of diseases and health conditions in pigs. Its purpose is to maintain healthy herds, prevent and control diseases, improve productivity, and ensure safe and efficient pork production. It also supports economic efficiency for farmers by reducing mortality and treatment costs, and contributes to food safety and public health by controlling zoonotic diseases.

The primary product types of swine healthcare include therapeutics, diagnostics, nutritional health, and services. Therapeutics refer to veterinary medicines such as antibiotics, vaccines, antiparasitics, and anti-inflammatory drugs used to prevent, manage, and treat diseases affecting swine health and productivity. The diseases addressed include exudative dermatitis, coccidiosis, respiratory diseases, swine dysentery, porcine parvovirus, and other diseases. The products are administered through injectable, oral, and intranasal or mucosal routes based on treatment protocols and disease conditions. The distribution channels include direct sales or veterinary channels, distributors and wholesalers, retail and online pharmacies, and service-integrated models. The end users of swine healthcare products and services include commercial farms, smallholder farms, and research institutes.

The swine healthcare market includes revenues earned by entities through the veterinary consultation, disease diagnosis and testing, herd health management, biosecurity management, parasite control services, reproductive health services, nutritional advisory services, animal welfare monitoring, health data management and reporting, and emergency veterinary services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The swine healthcare market research report is one of a series of new reports that provides swine healthcare market statistics, including swine healthcare industry global market size, regional shares, competitors with a swine healthcare market share, detailed swine healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the swine healthcare industry. This swine healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.